UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 131

Sortiert nach

Small cell carcinoma of the urinary bladder: The Mayo Clinic experience

Cancer, 2005-03, Vol.103 (6), p.1172-1178

2005

Link zum Volltext

Verfügbarkeit prüfen

MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer

Clinical cancer research, 2019-05, Vol.25 (10), p.2988-2995

2019

Link zum Volltext

Verfügbarkeit prüfen

EphA2 Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation

The Journal of biological chemistry, 2010-06, Vol.285 (24), p.18575-18585

2010

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Therapy with Bevacizumab in Hereditary Hemorrhagic Telangiectasia

The New England journal of medicine, 2011-02, Vol.364 (7), p.688-689

2011

Link zum Volltext

Verfügbarkeit prüfen

Continuous-Course Reirradiation With Concurrent Carboplatin and Paclitaxel for Locally Recurrent, Nonmetastatic Squamous Cell Carcinoma of the Head-and-Neck

International journal of radiation oncology, biology, physics, 2012-06, Vol.83 (2), p.690-695

2012

Link zum Volltext

Verfügbarkeit prüfen

Morbidities of lung cancer surgery in obese patients

The Journal of thoracic and cardiovascular surgery, 2013-08, Vol.146 (2), p.379-384

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of sunitinib malate in head and neck squamous cell carcinoma

Investigational new drugs, 2010-10, Vol.28 (5), p.677-683

2010

Link zum Volltext

Verfügbarkeit prüfen

Complete and Durable Response of Choroid Metastasis from Non-small Cell Lung Cancer with Systemic Bevacizumab and Chemotherapy

Journal of thoracic oncology, 2009-05, Vol.4 (5), p.661-662

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of Erlotinib-Based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer

Journal of thoracic oncology, 2008-09, Vol.3 (9), p.1003-1011

2008

Link zum Volltext

Verfügbarkeit prüfen

Intravenous and topical intranasal bevacizumab (Avastin) in hereditary hemorrhagic telangiectasia

American journal of otolaryngology, 2012-05, Vol.33 (3), p.349-351

2012

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptor directed therapy in head and neck cancer

Critical reviews in oncology/hematology, 2006, Vol.57 (1), p.25-43

2006

Link zum Volltext

Verfügbarkeit prüfen

Biomarker analysis of on-treatment and at progression biopsies from BRIM7 - a phase 1B trial of combined vemurafenib and cobimetinib treatment in BRAF V600 mutated melanoma

Journal of translational medicine, 2014-05, Vol.12 (S1), p.O12-O12, Article O12

2014

Link zum Volltext

Verfügbarkeit prüfen

Combination of vemurafenib and cobimetinib in patients with advanced BRAFV600 -mutated melanoma: a phase 1b study

The lancet oncology, 2014-08, Vol.15 (9), p.954-965

2014

Link zum Volltext

Verfügbarkeit prüfen

Recurrent Laryngeal Nerve Palsy on Integrated Positron Emission Tomography-Computed Tomography

Journal of thoracic oncology, 2008-10, Vol.3 (10), p.1172-1172

2008

Link zum Volltext

Verfügbarkeit prüfen

Intramural Gastric Abscess: Case History and Review

Gastrointestinal endoscopy, 2003-10, Vol.58 (4), p.627-629

2003

Link zum Volltext

Verfügbarkeit prüfen

Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma

The New England journal of medicine, 2014-11, Vol.371 (20), p.1867-1876

2014

Link zum Volltext

Verfügbarkeit prüfen

Stereotactic Radiosurgery for the Management of Brain Metastases

The New England journal of medicine, 2010-08, Vol.363 (6), p.591-593

2010

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction

Medical oncology (Northwood, London, England), 2011-12, Vol.28 (Suppl 1), p.152-161

2011

Link zum Volltext

Verfügbarkeit prüfen

Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b study

The lancet oncology, 2014-08, Vol.15 (9), p.954

2014

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic targeting of receptor tyrosine kinases in lung cancer

Expert opinion on therapeutic targets, 2005-06, Vol.9 (3), p.533-559

2005

Link zum Volltext

Verfügbarkeit prüfen

Expanding Role of the Medical Oncologist in the Management of Head and Neck Cancer

CA: a cancer journal for clinicians, 2008-01, Vol.58 (1), p.32-53

2008

Link zum Volltext

Verfügbarkeit prüfen

Key Signaling Pathways and Targets in Lung Cancer Therapy

Clinical lung cancer, 2007-02, Vol.8, p.S52-S60

2007

Link zum Volltext

Verfügbarkeit prüfen

Bilateral Carotid Body Paraganglioma

Mayo Clinic proceedings, 2004-05, Vol.79 (5), p.681-681

2004

Link zum Volltext

Verfügbarkeit prüfen

Tracheoesophageal Fistula Associated with Bevacizumab 21 Months after Completion of Radiation Therapy

Journal of thoracic oncology, 2009-12, Vol.4 (12), p.1590-1591

2009

Link zum Volltext

Verfügbarkeit prüfen

Pemetrexed Induced Pneumonitis

Clinics and practice, 2011-11, Vol.1 (4), p.e106

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 131

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(118)

Publikationsform

Sprache

Englisch
(129)
Japanisch
(15)
Spanisch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Small cell carcinoma of the urinary bladder: The Mayo Clinic experience

MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer

EphA2 Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation

Long-Term Therapy with Bevacizumab in Hereditary Hemorrhagic Telangiectasia

Continuous-Course Reirradiation With Concurrent Carboplatin and Paclitaxel for Locally Recurrent, Nonmetastatic Squamous Cell Carcinoma of the Head-and-Neck

Morbidities of lung cancer surgery in obese patients

Phase II study of sunitinib malate in head and neck squamous cell carcinoma

Complete and Durable Response of Choroid Metastasis from Non-small Cell Lung Cancer with Systemic Bevacizumab and Chemotherapy

Phase I Trial of Erlotinib-Based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer

Intravenous and topical intranasal bevacizumab (Avastin) in hereditary hemorrhagic telangiectasia

Epidermal growth factor receptor directed therapy in head and neck cancer

Biomarker analysis of on-treatment and at progression biopsies from BRIM7 - a phase 1B trial of combined vemurafenib and cobimetinib treatment in BRAF V600 mutated melanoma

Combination of vemurafenib and cobimetinib in patients with advanced BRAFV600 -mutated melanoma: a phase 1b study

Recurrent Laryngeal Nerve Palsy on Integrated Positron Emission Tomography-Computed Tomography

Intramural Gastric Abscess: Case History and Review

Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma

Stereotactic Radiosurgery for the Management of Brain Metastases

Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction

Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b study

Therapeutic targeting of receptor tyrosine kinases in lung cancer

Expanding Role of the Medical Oncologist in the Management of Head and Neck Cancer

Key Signaling Pathways and Targets in Lung Cancer Therapy

Bilateral Carotid Body Paraganglioma

Tracheoesophageal Fistula Associated with Bevacizumab 21 Months after Completion of Radiation Therapy

Pemetrexed Induced Pneumonitis

Suchergebnisse filtern